tradingkey.logo
tradingkey.logo
Pesquisar

Sonoma Pharmaceuticals Inc

SNOA
Adicionar à lista de desejos
1.210USD
0.0000.00%
Fechamento 07/02, 13:00ETCotações atrasadas em 15 min
2.09MValor de mercado
PerdaP/L TTM

Mais detalhes de Sonoma Pharmaceuticals Inc Empresa

Sonoma Pharmaceuticals, Inc. is a global healthcare company. The Company is engaged in developing and producing stabilized hypochlorous acid (HOCl) products for a range of applications, including wound care, eye care, nasal care, oral care, dermatological conditions, podiatry, animal health care and non-toxic disinfectants. Its products are all classified as medical devices and categorized as prescription, over-the-counter (OTC) and office dispense products. It offers both prescription and OTC dermatology products, including Epicyn Facial Cleanser, Levicyn Dermal Spray, Levicyn Gel, Levicyn Spray Gel, Celacyn Scar Management Gel. In the United States, it offers Microcyn wound and skin care both as an OTC and prescription product. Its eyecare products include Acuiycn Eyelid and Eyelash Hygiene, and Ocucyn Eyelid and Eyelash Cleanser. MicrocynAH is an HOCl-based topical product that cleans, debrides and treats a wide spectrum of animal wounds and infections.

Informações de Sonoma Pharmaceuticals Inc

Código da empresaSNOA
Nome da EmpresaSonoma Pharmaceuticals Inc
Data de listagemJan 26, 2007
CEOTrombly (Amy)
Número de funcionários168
Tipo de títulosOrdinary Share
Fim do ano fiscalJan 26
Endereço5445 Conestoga Court, Suite 150
CidadeBOULDER
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal80301
Telefone18007599305
Sitehttps://sonomapharma.com/
Código da empresaSNOA
Data de listagemJan 26, 2007
CEOTrombly (Amy)

Executivos da empresa Sonoma Pharmaceuticals Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Jay E. Birnbaum, Ph.D.
Dr. Jay E. Birnbaum, Ph.D.
Independent Director
Independent Director
286.00
-0.35%
Mr. Jerry G. Mclaughlin
Mr. Jerry G. Mclaughlin
Lead Independent Director
Lead Independent Director
--
--
Mr. Philippe Weigerstorfer
Mr. Philippe Weigerstorfer
Independent Director
Independent Director
--
--
Ms. Amy Trombly
Ms. Amy Trombly
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Jerry Dvonch
Mr. Jerry Dvonch
Chief Financial Officer
Chief Financial Officer
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Jay E. Birnbaum, Ph.D.
Dr. Jay E. Birnbaum, Ph.D.
Independent Director
Independent Director
286.00
-0.35%
Mr. Jerry G. Mclaughlin
Mr. Jerry G. Mclaughlin
Lead Independent Director
Lead Independent Director
--
--
Mr. Philippe Weigerstorfer
Mr. Philippe Weigerstorfer
Independent Director
Independent Director
--
--
Ms. Amy Trombly
Ms. Amy Trombly
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Jerry Dvonch
Mr. Jerry Dvonch
Chief Financial Officer
Chief Financial Officer
--
--

Perguntas frequentes

Quem são os cinco principais acionistas de Sonoma Pharmaceuticals Inc?

Os cinco principais acionistas de Sonoma Pharmaceuticals Inc são: Dr. Jay E. Birnbaum, Ph.D.

Quantas instituições possuem ações da Sonoma Pharmaceuticals Inc (SNOA)?

Em 2026Q1, 40 instituições possuíam ações da Sonoma Pharmaceuticals Inc, com valor de mercado aproximado de 127.80K, representando 3.68% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em -34692.00.

Qual é a maior fonte de receita da Sonoma Pharmaceuticals Inc?

Em 2026Q1, o segmento de negócios Human Care gerou a maior receita para Sonoma Pharmaceuticals Inc, totalizando 3.86M e representando 88.83% da receita total.